Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -43.83 Million USD | 20.94% |
| 2022 | -55.43 Million USD | 26.23% |
| 2021 | -75.14 Million USD | -0.28% |
| 2020 | -74.93 Million USD | 44.94% |
| 2019 | -136.09 Million USD | -52.84% |
| 2018 | -89.04 Million USD | 33.18% |
| 2017 | -133.25 Million USD | -27.81% |
| 2016 | -104.26 Million USD | 5.82% |
| 2015 | -110.7 Million USD | -10.53% |
| 2014 | -100.15 Million USD | -58.14% |
| 2013 | -63.33 Million USD | -83.75% |
| 2012 | -34.46 Million USD | -40.24% |
| 2011 | -24.57 Million USD | -59.57% |
| 2010 | -15.4 Million USD | -53.6% |
| 2009 | -10.02 Million USD | 75.89% |
| 2008 | -41.59 Million USD | -15.85% |
| 2007 | -35.9 Million USD | 23.88% |
| 2006 | -47.16 Million USD | -5.41% |
| 2005 | -44.74 Million USD | -13.75% |
| 2004 | -39.33 Million USD | -169.59% |
| 2003 | -14.59 Million USD | -32.64% |
| 2002 | -11 Million USD | -21.36% |
| 2001 | -9.06 Million USD | -9.67% |
| 2000 | -8.26 Million USD | -29.16% |
| 1999 | -6.4 Million USD | 40.19% |
| 1998 | -10.7 Million USD | 52.86% |
| 1997 | -22.7 Million USD | -740.74% |
| 1996 | -2.7 Million USD | -50.0% |
| 1995 | -1.8 Million USD | -12.5% |
| 1994 | -1.6 Million USD | 60.98% |
| 1993 | -4.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -34.74 Million USD | 13.47% |
| 2024 Q1 | -40.15 Million USD | 8.38% |
| 2024 Q3 | -60.07 Million USD | -0.25% |
| 2023 Q2 | -35.21 Million USD | 28.65% |
| 2023 Q1 | -49.35 Million USD | 10.98% |
| 2023 FY | -43.83 Million USD | 20.94% |
| 2023 Q4 | -43.83 Million USD | -1.0% |
| 2023 Q3 | -43.39 Million USD | -23.25% |
| 2022 FY | -55.43 Million USD | 26.23% |
| 2022 Q4 | -55.43 Million USD | 2.18% |
| 2022 Q2 | -59.78 Million USD | 14.41% |
| 2022 Q1 | -69.85 Million USD | 7.04% |
| 2022 Q3 | -56.67 Million USD | 5.21% |
| 2021 Q4 | -75.14 Million USD | -7.67% |
| 2021 FY | -75.14 Million USD | -0.28% |
| 2021 Q1 | -72.42 Million USD | 3.36% |
| 2021 Q2 | -75.57 Million USD | -4.36% |
| 2021 Q3 | -69.79 Million USD | 7.65% |
| 2020 Q1 | -44.1 Million USD | 67.59% |
| 2020 Q2 | -45.33 Million USD | -2.79% |
| 2020 Q3 | -56.45 Million USD | -24.54% |
| 2020 Q4 | -74.93 Million USD | -32.73% |
| 2020 FY | -74.93 Million USD | 44.94% |
| 2019 Q2 | -47.43 Million USD | 35.27% |
| 2019 Q1 | -73.28 Million USD | 17.7% |
| 2019 Q4 | -136.09 Million USD | -66.42% |
| 2019 Q3 | -81.77 Million USD | -72.41% |
| 2019 FY | -136.09 Million USD | -52.84% |
| 2018 Q3 | -81.82 Million USD | 35.08% |
| 2018 Q2 | -126.04 Million USD | 11.11% |
| 2018 FY | -89.04 Million USD | 33.18% |
| 2018 Q1 | -141.79 Million USD | -6.41% |
| 2018 Q4 | -89.04 Million USD | -8.82% |
| 2017 Q4 | -133.25 Million USD | -4.96% |
| 2017 Q2 | -117.87 Million USD | 1.25% |
| 2017 Q3 | -126.96 Million USD | -7.71% |
| 2017 Q1 | -119.36 Million USD | -14.49% |
| 2017 FY | -133.25 Million USD | -27.81% |
| 2016 Q2 | -89.12 Million USD | 4.0% |
| 2016 Q3 | -98.04 Million USD | -10.01% |
| 2016 FY | -104.26 Million USD | 5.82% |
| 2016 Q1 | -92.83 Million USD | 16.14% |
| 2016 Q4 | -104.26 Million USD | -6.34% |
| 2015 Q4 | -110.7 Million USD | -2.06% |
| 2015 Q3 | -108.46 Million USD | -4.38% |
| 2015 FY | -110.7 Million USD | -10.53% |
| 2015 Q1 | -99.8 Million USD | 0.35% |
| 2015 Q2 | -103.92 Million USD | -4.13% |
| 2014 Q3 | -71.77 Million USD | 15.44% |
| 2014 Q2 | -84.87 Million USD | -3.31% |
| 2014 Q4 | -100.15 Million USD | -39.55% |
| 2014 Q1 | -82.16 Million USD | -29.73% |
| 2014 FY | -100.15 Million USD | -58.14% |
| 2013 Q1 | -41.76 Million USD | -21.17% |
| 2013 Q4 | -63.33 Million USD | -13.8% |
| 2013 Q3 | -55.65 Million USD | -22.75% |
| 2013 Q2 | -45.34 Million USD | -8.56% |
| 2013 FY | -63.33 Million USD | -83.75% |
| 2012 FY | -34.46 Million USD | -40.24% |
| 2012 Q2 | -27.5 Million USD | -18.56% |
| 2012 Q4 | -34.46 Million USD | -15.45% |
| 2012 Q3 | -29.85 Million USD | -8.53% |
| 2012 Q1 | -23.2 Million USD | 5.59% |
| 2011 FY | -24.57 Million USD | -59.57% |
| 2011 Q4 | -24.57 Million USD | -40.85% |
| 2011 Q3 | -17.44 Million USD | -17.67% |
| 2011 Q2 | -14.82 Million USD | 11.09% |
| 2011 Q1 | -16.67 Million USD | -8.29% |
| 2010 FY | -15.4 Million USD | -53.6% |
| 2010 Q2 | -10.04 Million USD | -9.61% |
| 2010 Q3 | -12.56 Million USD | -25.05% |
| 2010 Q1 | -9.16 Million USD | 8.57% |
| 2010 Q4 | -15.4 Million USD | -22.57% |
| 2009 Q3 | -23.74 Million USD | 2.5% |
| 2009 FY | -10.02 Million USD | 75.89% |
| 2009 Q2 | -24.34 Million USD | 1.92% |
| 2009 Q1 | -24.82 Million USD | 40.31% |
| 2009 Q4 | -10.02 Million USD | 57.76% |
| 2008 Q3 | -27.36 Million USD | 6.58% |
| 2008 Q4 | -41.59 Million USD | -51.98% |
| 2008 FY | -41.59 Million USD | -15.85% |
| 2008 Q1 | -34.95 Million USD | 2.65% |
| 2008 Q2 | -29.29 Million USD | 16.18% |
| 2007 Q4 | -35.9 Million USD | 22.22% |
| 2007 Q2 | -44.75 Million USD | -2.22% |
| 2007 Q1 | -43.78 Million USD | 7.18% |
| 2007 Q3 | -46.15 Million USD | -3.15% |
| 2007 FY | -35.9 Million USD | 23.88% |
| 2006 FY | -47.16 Million USD | -5.41% |
| 2006 Q2 | -46.12 Million USD | -3.75% |
| 2006 Q3 | -47.42 Million USD | -2.8% |
| 2006 Q4 | -47.16 Million USD | 0.53% |
| 2006 Q1 | -44.45 Million USD | 0.64% |
| 2005 Q2 | -39.93 Million USD | 1.01% |
| 2005 Q3 | -45.87 Million USD | -14.88% |
| 2005 Q4 | -44.74 Million USD | 2.45% |
| 2005 Q1 | -40.33 Million USD | -2.54% |
| 2005 FY | -44.74 Million USD | -13.75% |
| 2004 Q1 | -34.49 Million USD | -136.42% |
| 2004 Q4 | -39.33 Million USD | -15.69% |
| 2004 Q3 | -34 Million USD | -1.39% |
| 2004 Q2 | -33.53 Million USD | 2.79% |
| 2004 FY | -39.33 Million USD | -169.59% |
| 2003 Q4 | -14.59 Million USD | -15.71% |
| 2003 Q1 | -10.49 Million USD | 4.65% |
| 2003 Q2 | -11.45 Million USD | -9.18% |
| 2003 FY | -14.59 Million USD | -32.64% |
| 2003 Q3 | -12.61 Million USD | -10.11% |
| 2002 FY | -11 Million USD | -21.36% |
| 2002 Q4 | -11 Million USD | -52.78% |
| 2002 Q3 | -7.2 Million USD | 3.7% |
| 2002 Q1 | -10.44 Million USD | -15.25% |
| 2002 Q2 | -7.47 Million USD | 28.43% |
| 2001 FY | -9.06 Million USD | -9.67% |
| 2001 Q1 | -6.38 Million USD | 22.73% |
| 2001 Q2 | -8.26 Million USD | -29.39% |
| 2001 Q3 | 19.18 Million USD | 332.12% |
| 2001 Q4 | -9.06 Million USD | -147.26% |
| 2000 Q4 | -8.26 Million USD | -45.57% |
| 2000 Q1 | -8.94 Million USD | -39.79% |
| 2000 FY | -8.26 Million USD | -29.16% |
| 2000 Q2 | -5.46 Million USD | 38.86% |
| 2000 Q3 | -5.67 Million USD | -3.82% |
| 1999 Q4 | -6.4 Million USD | -357.14% |
| 1999 FY | -6.4 Million USD | 40.19% |
| 1999 Q3 | -1.4 Million USD | 73.08% |
| 1999 Q1 | -5.6 Million USD | 47.66% |
| 1999 Q2 | -5.2 Million USD | 7.14% |
| 1998 Q3 | -12.7 Million USD | 45.96% |
| 1998 Q1 | -22.4 Million USD | 1.32% |
| 1998 Q2 | -23.5 Million USD | -4.91% |
| 1998 Q4 | -10.7 Million USD | 15.75% |
| 1998 FY | -10.7 Million USD | 52.86% |
| 1997 Q3 | -3.1 Million USD | -6.9% |
| 1997 Q1 | -2.5 Million USD | 13.79% |
| 1997 FY | -22.7 Million USD | -740.74% |
| 1997 Q2 | -2.9 Million USD | -16.0% |
| 1997 Q4 | -22.7 Million USD | -632.26% |
| 1996 Q4 | -2.9 Million USD | 21.62% |
| 1996 Q2 | -4 Million USD | -700.0% |
| 1996 Q1 | -500 Thousand USD | 58.33% |
| 1996 FY | -2.7 Million USD | -50.0% |
| 1996 Q3 | -3.7 Million USD | 7.5% |
| 1995 Q3 | -1.8 Million USD | 21.74% |
| 1995 Q4 | -1.2 Million USD | 33.33% |
| 1995 Q1 | -600 Thousand USD | 40.0% |
| 1995 Q2 | -2.3 Million USD | -283.33% |
| 1995 FY | -1.8 Million USD | -12.5% |
| 1994 FY | -1.6 Million USD | 60.98% |
| 1994 Q1 | -2.5 Million USD | 28.57% |
| 1994 Q3 | -1.6 Million USD | 30.43% |
| 1994 Q4 | -1 Million USD | 37.5% |
| 1994 Q2 | -2.3 Million USD | 8.0% |
| 1993 FY | -4.1 Million USD | 0.0% |
| 1993 Q3 | -4.1 Million USD | 8.89% |
| 1993 Q2 | -4.5 Million USD | 0.0% |
| 1993 Q4 | -3.5 Million USD | 14.63% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 261.842% |
| BrainsWay Ltd. | -10.32 Million USD | -324.709% |
| Cerus Corporation | 84.35 Million USD | 151.961% |
| Envoy Medical, Inc. | -3.81 Million USD | -1049.187% |
| electroCore, Inc. | -9.95 Million USD | -340.281% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | -755.22% |
| IceCure Medical Ltd | -9.93 Million USD | -341.212% |
| Inogen, Inc. | -103.56 Million USD | 57.68% |
| OrthoPediatrics Corp. | -9.26 Million USD | -372.969% |
| Lucid Diagnostics Inc. | -3.64 Million USD | -1103.79% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | -234.656% |
| MaxCyte, Inc. | -27.76 Million USD | -57.872% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | -753.04% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -7512.454% |
| Orthofix Medical Inc. | 96.44 Million USD | 145.447% |
| PAVmed Inc | 29.08 Million USD | 250.691% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | -158.752% |
| RxSight, Inc. | -6.68 Million USD | -556.138% |
| Sight Sciences, Inc. | -102.71 Million USD | 57.329% |
| SI-BONE, Inc. | 5.72 Million USD | 866.125% |
| TELA Bio, Inc. | -3.94 Million USD | -1009.901% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 176.464% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 12551.705% |
| Acutus Medical, Inc. | 12.27 Million USD | 456.951% |
| Talis Biomedical Corporation | -57.06 Million USD | 23.192% |
| Spectral AI, Inc. | -3.5 Million USD | -1151.928% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 8.739% |
| CVRx, Inc. | -59.95 Million USD | 26.896% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 2309.012% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 3530.552% |
| Bioventus Inc. | 372.51 Million USD | 111.766% |
| Venus Concept Inc. | 74.3 Million USD | 158.99% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | -330.466% |
| LivaNova PLC | 62.53 Million USD | 170.092% |
| 908 Devices Inc. | -115.09 Million USD | 61.919% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 113.667% |
| Nemaura Medical Inc. | 9.92 Million USD | 541.611% |
| NeuroPace, Inc. | 54.33 Million USD | 180.663% |
| LENSAR, Inc. | -18.31 Million USD | -139.351% |
| Apyx Medical Corporation | -5.15 Million USD | -750.903% |
| Cutera, Inc. | 288.3 Million USD | 115.203% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 683.234% |
| BioSig Technologies, Inc. | 262 Thousand USD | 16829.008% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | -376.465% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 103.119% |
| Axonics, Inc. | -77.19 Million USD | 43.221% |
| Outset Medical, Inc. | 67.67 Million USD | 164.762% |
| IRIDEX Corporation | -4.28 Million USD | -922.155% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 75.379% |
| IRadimed Corporation | -47.71 Million USD | 8.15% |
| Tivic Health Systems, Inc. | -3.02 Million USD | -1348.447% |
| INVO Bioscience, Inc. | 8.45 Million USD | 618.628% |
| Telesis Bio, Inc. | 32.63 Million USD | 234.304% |
| Viemed Healthcare, Inc. | -2.5 Million USD | -1651.706% |
| Varex Imaging Corporation | 316.9 Million USD | 113.831% |
| Quipt Home Medical Corp. | 81.73 Million USD | 153.625% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1475.485% |
| Pulmonx Corporation | -42.36 Million USD | -3.47% |
| Dynatronics Corporation | 6.2 Million USD | 806.476% |
| Modular Medical, Inc. | -8.04 Million USD | -445.014% |
| ReShape Lifesciences Inc. | -4.29 Million USD | -920.014% |
| Semler Scientific, Inc. | -57.13 Million USD | 23.28% |
| InMode Ltd. | -135.39 Million USD | 67.628% |
| Bruker Corporation | 891.3 Million USD | 104.918% |
| Cytosorbents Corporation | 4.18 Million USD | 1148.059% |
| DexCom, Inc. | 2.02 Billion USD | 102.162% |
| Align Technology, Inc. | -840.47 Million USD | 94.785% |
| Viveve Medical, Inc. | -13.81 Million USD | -217.31% |
| ZimVie Inc. | 450.41 Million USD | 109.731% |
| Movano Inc. | -5.86 Million USD | -647.187% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 67.402% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | -7512.454% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 2309.012% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 112.284% |
| Profound Medical Corp. | -18.17 Million USD | -141.109% |
| Insulet Corporation | 798.1 Million USD | 105.492% |
| enVVeno Medical Corporation | -2.21 Million USD | -1876.105% |
| Surmodics, Inc. | -12.01 Million USD | -264.824% |
| iCAD, Inc. | -21.2 Million USD | -106.658% |
| Nuwellis, Inc. | -2.81 Million USD | -1454.807% |
| Biotricity, Inc. | 23.09 Million USD | 289.8% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 146.801% |
| Aethlon Medical, Inc. | -4.5 Million USD | -873.64% |
| InspireMD, Inc. | -8.04 Million USD | -444.81% |
| PAVmed Inc. | 29.08 Million USD | 250.691% |
| BIOLASE, Inc. | 11.34 Million USD | 486.372% |
| Beyond Air, Inc. | 6.22 Million USD | 803.644% |
| FONAR Corporation | -14.66 Million USD | -198.868% |
| AxoGen, Inc. | 32.26 Million USD | 235.84% |
| Vivani Medical, Inc. | 42 Thousand USD | 104457.143% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | -311.24% |
| Inari Medical, Inc. | -7.16 Million USD | -512.065% |
| UFP Technologies, Inc. | 40.77 Million USD | 207.495% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 1528.327% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | -818.616% |
| Tenon Medical, Inc. | -1.25 Million USD | -3392.43% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | -476.256% |
| Co-Diagnostics, Inc. | -11.92 Million USD | -267.507% |
| AdaptHealth Corp. | 2.21 Billion USD | 101.977% |
| Sintx Technologies, Inc. | 905 Thousand USD | 4943.094% |
| NanoVibronix, Inc. | -3.27 Million USD | -1237.096% |
| Quanterix Corporation | -132.95 Million USD | 67.035% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | -1475.485% |
| Sensus Healthcare, Inc. | -22.36 Million USD | -95.976% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 105.815% |
| TransMedics Group, Inc. | 121.13 Million USD | 136.183% |
| ReWalk Robotics Ltd. | -26.18 Million USD | -67.418% |
| NeuroMetrix, Inc. | -1.49 Million USD | -2839.5% |
| Hyperfine, Inc. | -75.61 Million USD | 42.038% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 128.8% |
| Biomerica, Inc. | -3.38 Million USD | -1194.83% |
| Bone Biologics Corporation | -3.02 Million USD | -1348.174% |
| AVITA Medical, Inc. | -26.23 Million USD | -67.088% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | -2284.124% |
| Silk Road Medical, Inc | 64.42 Million USD | 168.035% |